HB
Hooi Bien Chuah
About Hooi Bien Chuah
Data last updated:
Hooi Bien Chuah is a Director at Astrazeneca Pharma India Limited (since 2023). The company operates in Pharma. Astrazeneca Pharma India Limited reported revenue of ₹1,757 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Astrazeneca Pharma India Limited L24231KA1979PLC003563 | Director | 09 Nov 2023 | 1979 | ₹1,757 Cr (FY 2025) | Active |
Board colleagues of Hooi Bien Chuah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Revathy | 00057539 | Astrazeneca Pharma India Limited | Director |
| Bhavana Agrawal | 10485441 | Astrazeneca Pharma India Limited | Whole-Time Director |
| Bhavana Agrawal | Astrazeneca Pharma India Limited | Cfo | |
| Monica | 07674403 | Astrazeneca Pharma India Limited | Director |
| Praveen Rao Akkinepally | 11137771 | Astrazeneca Pharma India Limited | Managing Director |
| Shilpa Divekar Nirula | 06619353 | Astrazeneca Pharma India Limited | Director |
| Tanya Sanish | Astrazeneca Pharma India Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hooi Bien Chuah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hooi Bien Chuah
Hooi Bien Chuah currently holds 1 directorship: Astrazeneca Pharma India Limited (Director, since 09 Nov 2023, revenue ₹1,757 Cr (FY 2025)).
Hooi Bien Chuah was first appointed on 09 Nov 2023 as Director at Astrazeneca Pharma India Limited.
The current boards of Hooi Bien Chuah's companies include Ashok Revathy (Astrazeneca Pharma India Limited), Bhavana Agrawal (Astrazeneca Pharma India Limited), Bhavana Agrawal (Astrazeneca Pharma India Limited), Monica (Astrazeneca Pharma India Limited), Praveen Rao Akkinepally (Astrazeneca Pharma India Limited), Shilpa Divekar Nirula (Astrazeneca Pharma India Limited), among others.